Literature DB >> 15833829

Spontaneous human adult stem cell transformation.

Daniel Rubio1, Javier Garcia-Castro, María C Martín, Ricardo de la Fuente, Juan C Cigudosa, Alison C Lloyd, Antonio Bernad.   

Abstract

Human adult stem cells are being evaluated widely for various therapeutic approaches. Several recent clinical trials have reported their safety, showing them to be highly resistant to transformation. The clear similarities between stem cell and cancer stem cell genetic programs are nonetheless the basis of a recent proposal that some cancer stem cells could derive from human adult stem cells. Here we show that although they can be managed safely during the standard ex vivo expansion period (6-8 weeks), human mesenchymal stem cells can undergo spontaneous transformation following long-term in vitro culture (4-5 months). This is the first report of spontaneous transformation of human adult stem cells, supporting the hypothesis of cancer stem cell origin. Our findings indicate the importance of biosafety studies of mesenchymal stem cell biology to efficiently exploit their full clinical therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833829     DOI: 10.1158/0008-5472.CAN-04-4194

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  281 in total

1.  p53 in stem cells.

Authors:  Valeriya Solozobova; Christine Blattner
Journal:  World J Biol Chem       Date:  2011-09-26

2.  Chromosomal stability during ex vivo expansion of UCB CD34(+) cells.

Authors:  J Ge; H Cai; W S Tan
Journal:  Cell Prolif       Date:  2011-10-04       Impact factor: 6.831

Review 3.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

4.  Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.

Authors:  Kurt E J Dittmar; Meike Simann; Nadia Zghoul; Oliver Schön; Wilhelm Meyring; Horst Hannig; Lars Macke; Wilhelm G Dirks; Konstantin Miller; Henk S P Garritsen; Werner Lindenmaier
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

Review 5.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 6.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 7.  Adipose tissue-derived stem cells: the friendly side of a classic cardiovascular foe.

Authors:  Ricardo Sanz-Ruiz; María Eugenia Fernández Santos; Marta Domínguez Muñoa; Ingrid Ludwig Martín; Radoslaw Parma; Pedro L Sánchez Fernández; Francisco Fernández-Avilés
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

Review 8.  The stem cell niche should be a key issue for cell therapy in regenerative medicine.

Authors:  José Becerra; Leonor Santos-Ruiz; José A Andrades; Manuel Marí-Beffa
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

9.  Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord.

Authors:  Ingrida Majore; Pierre Moretti; Frank Stahl; Ralf Hass; Cornelia Kasper
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

10.  Defining the probability that a cell therapy will produce a malignancy.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2010-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.